|
1
|
Akamatsu N, Cillo U, Cucchetti A, Donadon
M, Pinna AD, Torzilli G and Kokudo N: Surgery and hepatocellular
carcinoma. Liver Cancer. 6:44–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tseng TC and Kao JH: HBV markers for HCC
prediction: Three heads are better than two? J Hepatol. 67:203–204.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou SJ, Deng YL, Liang HF, Jaoude JC and
Liu FY: Hepatitis B virus X protein promotes CREB-mediated
activation of miR-3188 and Notch signaling in hepatocellular
carcinoma. Cell Death Differ. 24:1577–1587. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang ST, Yen CJ, Lai CH, Lin YJ, Chang KC,
Lee JC, Liu YW, Chang-Liao PY, Hsu LS, Chang WC, et al: SUMOylated
CPAP is required for IKK-mediated NF-κB activation and enhances
HBx-induced NF-κB signaling in HCC. J Hepatol. 58:1157–1164. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y,
Zhang X, Guo J and Li M: HBx drives alpha fetoprotein expression to
promote initiation of liver cancer stem cells through activating
PI3K/AKT signal pathway. Int J Cancer. 140:1346–1355. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen S, Dong Z, Yang P, Wang X, Jin G, Yu
H, Chen L, Li L, Tang L, Bai S, et al: Hepatitis B virus X protein
stimulates high mobility group box 1 secretion and enhances
hepatocellular carcinoma metastasis. Cancer Lett. 394:22–32. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fusco A and Fedele M: Roles of HMGA
proteins in cancer. Nat Rev Cancer. 7:899–910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Franco R, Esposito F, Fedele M, Liguori G,
Pierantoni GM, Botti G, Tramontano D, Fusco A and Chieffi P:
Detection of high-mobility group proteins A1 and A2 represents a
valid diagnostic marker in post-pubertal testicular germ cell
tumours. J Pathol. 214:58–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun M, Gomes S, Chen P, Frankenberger CA,
Sankarasharma D, Chung CH, Chada KK and Rosner MR: RKIP and HMGA2
regulate breast tumor survival and metastasis through lysyl oxidase
and syndecan-2. Oncogene. 33:3528–3537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piton N, Angot É, Marguet F and Sabourin
JC: HMGA2 immunostaining is a straightforward technique which helps
to distinguish pulmonary fat-forming lesions from normal adipose
tissue in small biopsies: A retrospective observational study about
a series of 13 lung biopsies. Diagn Pathol. 12:212017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu J, Zhang S, Shan J, Hu Z, Liu X, Chen
L, Ren X, Yao L, Sheng H, Li L, et al: Elevated HMGA2 expression is
associated with cancer aggressiveness and predicts poor outcome in
breast cancer. Cancer Lett. 376:284–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong J, Wang R, Ren G, Li X, Wang J, Sun
Y, Liang J, Nie Y, Wu K, Feng B, et al: HMGA2-FOXL2 axis regulates
metastases and epithelial-to-mesenchymal transition of
chemoresistant gastric cancer. Clin Cancer Res. 23:3461–3473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Tang J, Cai X, Huang Y, Gao Q,
Liang L, Tian L, Yang Y, Zheng Y, Hu Y and Tang N: HBx mutations
promote hepatoma cell migration through the Wnt/β-catenin signaling
pathway. Cancer Sci. 107:1380–1389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ha HL, Kwon T, Bak IS, Erikson RL, Kim BY
and Yu DY: IGF-II induced by hepatitis B virus X protein regulates
EMT via SUMO mediated loss of E-cadherin in mice. Oncotarget.
7:56944–56957. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Agostini A, Panagopoulos I, Andersen HK,
Johannesen LE, Davidson B, Tropé CG, Heim S and Micci F: HMGA2
expression pattern and TERT mutations in tumors of the vulva. Oncol
Rep. 33:2675–2680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You
T: HMGA2 induces transcription factor Slug expression to promote
epithelial-to-mesenchymal transition and contributes to colon
cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo SP, Wang WL, Zhai YQ and Zhao YL:
Expression of nuclear factor-kappa B in hepatocellular carcinoma
and its relation with the X protein of hepatitis B virus. World J
Gastroenterol. 7:340–344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin Y, Wu D, Yang W, Weng M, Li Y, Wang X,
Zhang X, Jin X and Wang T: Hepatitis B virus × protein induces
epithelial-mesenchymal transition of hepatocellular carcinoma cells
by regulating long non-coding RNA. Virol J. 14:2382017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou Z, Xu X, Fu X, Tao S, Zhou J, Liu S
and Tan D: HBx-related long non-coding RNA MALAT1 promotes cell
metastasis via up-regulating LTBP3 in hepatocellular carcinoma. Am
J Cancer Res. 7:845–856. 2017.PubMed/NCBI
|
|
20
|
Ou W, Lv J, Zou X, Yao Y, Wu J, Yang J,
Wang Z and Ma Y: Propofol inhibits hepatocellular carcinoma growth
and invasion through the HMGA2-mediated Wnt/β-catenin pathway. Exp
Ther Med. 13:2501–2506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo Y, Li W and Liao H: HMGA2 induces
epithelial-to-mesenchymal transition in human hepatocellular
carcinoma cells. Oncol Lett. 5:1353–1356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Chen F, Zhao M, Yang Z, Li J,
Zhang S, Zhang W, Ye L and Zhang X: The long noncoding RNA HULC
promotes liver cancer by increasing the expression of the HMGA2
oncogene via sequestration of the microRNA-186. J Biol Chem.
292:15395–15407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Xu Y, Ma H, Wang B, Xu L, Zhang H,
Song X, Gao L, Liang X and Ma C: Hepatitis B virus X protein
amplifies TGF-β promotion on HCC motility through down-regulating
PPM1a. Oncotarget. 7:33125–33123. 2016.PubMed/NCBI
|
|
24
|
Murata M, Matsuzaki K, Yoshida K, Sekimoto
G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, et
al: Hepatitis B virus X protein shifts human hepatic transforming
growth factor (TGF)-beta signaling from tumor suppression to
oncogenesis in early chronic hepatitis B. Hepatology. 49:1203–1217.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morishita A, Zaidi MR, Mitoro A,
Sankarasharma D, Szabolcs M, Okada Y, D'Armiento J and Chada K:
HMGA2 is a driver of tumor metastasis. Cancer Res. 73:4289–4299.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu S, Zhou RR, Li N, Huang Y and Fan XG:
Hepatitis B virus X protein in liver tumor microenvironment. Tumour
Biol. Sep 23–2016.(Epub ahead of print). View Article : Google Scholar
|
